Pazopanib in rare histologies of metastatic soft tissue sarcoma

BACKGROUND: Uncommon histopathological subtypes account for less than 5% cases of soft tissue sarcoma (STS) and unclassified STSs comprise another 16%, these are often chemotherapy-resistant, with a dismal outcome in unresectable/metastatic disease. Prospective studies on the use of pazopanib in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataria, Babita, Sharma, Aparna, Biswas, Bivas, Bakhshi, Sameer, Pushpam, Deepam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580588/
https://www.ncbi.nlm.nih.gov/pubmed/34824604
http://dx.doi.org/10.3332/ecancer.2021.1281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580588/
https://www.ncbi.nlm.nih.gov/pubmed/34824604
http://dx.doi.org/10.3332/ecancer.2021.1281

Ejemplares similares